Publications

Li, Z., Wang, Y., Ding, Y., Repp, L., Kwon, G. S., Hu, Q., Cell-Based Delivery Systems: Emerging Carriers for Immunotherapy. Adv. Funct. Mater. 2021, 31, 2100088. https://doi.org/10.1002/adfm.202100088

Repp, L., Rasoulianboroujeni, M., Lee, H. J., & Kwon, G. S. (2021). Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection. Journal of controlled release : official journal of the Controlled Release Society, 330, 1004–1015. https://doi.org/10.1016/j.jconrel.2020.11.008

Zbyszynski, P., Toraason, I., Repp, L., & Kwon, G. S. (2019). Probing the subcutaneous absorption of a PEGylated FUD peptide nanomedicine via in vivo fluorescence imaging. Nano convergence, 6(1), 22. https://doi.org/10.1186/s40580-019-0192-3

Cote, B., Rao, D., Alany, R. G., Kwon, G. S., & Alani, A. (2019). Lymphatic changes in cancer and drug delivery to the lymphatics in solid tumors. Advanced drug delivery reviews, 144, 16–34. https://doi.org/10.1016/j.addr.2019.08.009

Tam, Y. T., Shin, D. H., Chen, K. E., & Kwon, G. S. (2019). Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)8-paclitaxel prodrug: In Vivo conversion and antitumor efficacy. Journal of controlled release : official journal of the Controlled Release Society, 298, 186–193. https://doi.org/10.1016/j.jconrel.2019.02.017

Tam, Y. T., Repp, L., Ma, Z. X., Feltenberger, J. B., & Kwon, G. S. (2019). Oligo(Lactic Acid)8-Rapamycin Prodrug-Loaded Poly(Ethylene Glycol)-block-Poly(Lactic Acid) Micelles for Injection. Pharmaceutical research, 36(5), 70. https://doi.org/10.1007/s11095-019-2600-0

Tomasini-Johansson, B. R., Zbyszynski, P. W., Toraason, I., Peters, D. M., & Kwon, G. S. (2018). PEGylated pUR4/FUD peptide inhibitor of fibronectin fibrillogenesis decreases fibrosis in murine Unilateral Ureteral Obstruction model of kidney disease. PloS one, 13(10), e0205360. https://doi.org/10.1371/journal.pone.0205360

Tam, Y. T., Huang, C., Poellmann, M., & Kwon, G. S. (2018). Stereocomplex Prodrugs of Oligo(lactic acid) n-Gemcitabine in Poly(ethylene glycol)- block-poly(d,l-lactic acid) Micelles for Improved Physical Stability and Enhanced Antitumor Efficacy. ACS nano, 12(7), 7406–7414. https://doi.org/10.1021/acsnano.8b04205

Zbyszynski, P., Tomasini-Johansson, B. R., Peters, D. M., & Kwon, G. S. (2018). Characterization of the PEGylated Functional Upstream Domain Peptide (PEG-FUD): a Potent Fibronectin Assembly Inhibitor with Potential as an Anti-Fibrotic Therapeutic. Pharmaceutical research, 35(7), 126. https://doi.org/10.1007/s11095-018-2412-7

Shin, D. H., & Kwon, G. S. (2017). Pre-clinical evaluation of a themosensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model. Journal of controlled release : official journal of the Controlled Release Society, 268, 176–183. https://doi.org/10.1016/j.jconrel.2017.10.022